Diagnostic Imaging Pathways Logo

  • Pathways
  • Normal Anatomy
  • Medical Images
  • Radiation Module
  • Radiation Quiz
  • Menu
  • Search

Hip Avascular Necrosis (Suspected)

Population Covered By The Guidance

This pathway provides guidance for imaging patients with suspected avascular necrosis of the hip.

Lead Researcher: Kieran Kusel

Experts & Contributors: Ravinder Dhillon, Eamon Koh, Michael Mason

Date reviewed: April 2019

Date Published: December 2025

Image 1 (Plain Radiograph): Flattening of the left femoral head is consistent with avascular necrosis.

Avascular Necrosis of the Left Femoral Head

Image 2 (Magnetic Resonance Imaging): MRI images of avascular necrosis demonstrating flattening and sclerosis of the superior articular surface of the left femur (arrow). Cortical fragmentation and marrow oedema are present within the femoral head.

Avascular Necrosis of the Left Femoral Head

Image 3 (Magnetic Resonance Imaging): Coronal T1 imaged showing bilateral avascular necrosis of differing age.

Avascular Necrosis of Bilateral Femoral Heads

Image 4 (H&E, x2.5): Histological section showing the features of avascular bone necrosis. There is necrosis of the bony trabeculae with empty lacunae and almost complete absence of haemopoeitic marrow elements.

Avascular Necrosis of the Femoral Head

  • Avascular necrosis of the femoral head (AVN) is the pathologic death of bone and marrow cells resulting from an interruption to their blood supply.
  • This can result in collapse and deformation of the femur which can lead to secondary osteoarthritis, loss of hip function and reduced quality of life.
  • AVN can be non-traumatic or occur following trauma.
  • Plain radiography is usually the initial imaging performed, however, it has a low sensitivity for detecting AVN, particularly in its early stages.
  • MRI is the most accurate imaging modality for detecting early AVN and should be performed when there is a high clinical suspicion.
  • Bone scintigraphy or CT can be helpful if MRI is unavailable or contraindicated.
  • Most patients will ultimately require hip arthroplasty.
  • Early diagnosis and treatment is useful to delay the need for joint replacement, particularly because non-traumatic AVN typically occurs in people aged between 30-50 years.

Date of literature search: April 2019

References are graded from Level I to V according to the Oxford Centre for Evidence-Based Medicine, Levels of Evidence. Download the document

1. Zhang YZ, Cao XY, Li XC, Chen J, Zhao YY, Tian Z, et al. Accuracy of MRI diagnosis of early osteonecrosis of the femoral head: a meta-analysis and systematic review. J Orthop Surg Res. 2018;13(1):167 (Level I evidence). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031173/

2. Murphey MD, Roberts CC, Bencardino JT, Appel M, Arnold E, Chang EY, et al. ACR Appropriateness Criteria Osteonecrosis of the Hip. J Am Coll Radiol. 2016;13(2):147-55 (Clinical guidelines). https://www.ncbi.nlm.nih.gov/pubmed/26846390

3. Azzali E, Milanese G, Martella I, Ruggirello M, Seletti V, Ganazzoli C, et al. Imaging of osteonecrosis of the femoral head. Acta Biomed. 2016;87 Suppl 3:6-12 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/27467861

4. Cohen-Rosenblum A, Cui Q. Osteonecrosis of the Femoral Head. Orthop Clin North Am. 2019;50(2):139-49 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/30850073

5. Arbab D, Konig DP. Atraumatic Femoral Head Necrosis in Adults. Dtsch Arztebl Int. 2016;113(3):31-8 (Review article). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748149/

6. Zalavras CG, Lieberman JR. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg. 2014;22(7):455-64 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/24966252

7. Babis GC, Sakellariou V, Parvizi J, Soucacos P. Osteonecrosis of the femoral head. Orthopedics. 2011;34(1):39 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/21210589

8. Amanatullah DF, Strauss EJ, Di Cesare PE. Current management options for osteonecrosis of the femoral head: part 1, diagnosis and nonoperative management. Am J Orthop (Belle Mead NJ). 2011;40(9):E186-92 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/22022684

9. Guerado E, Caso E. The physiopathology of avascular necrosis of the femoral head: an update. Injury. 2016;47 Suppl 6:S16-s26 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/28040082

10. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002;32(2):94-124 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/12430099

11. Fukushima W, Fujioka M, Kubo T, Tamakoshi A, Nagai M, Hirota Y. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res. 2010;468(10):2715-24 (Level IV evidence). https://www.ncbi.nlm.nih.gov/pubmed/20224959

12. Mont MA, Cherian JJ, Sierra RJ, Jones LC, Lieberman JR. Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today? A Ten-Year Update. J Bone Joint Surg Am. 2015;97(19):1604-27 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/26446969

13. Lee GC, Steinberg ME. Are we evaluating osteonecrosis adequately? Int Orthop. 2012;36(12):2433-9 (Level II evidence). https://www.ncbi.nlm.nih.gov/pubmed/23011722

14. Lee MS, Hsieh PH, Shih CH, Wang CJ. Non-traumatic osteonecrosis of the femoral head - from clinical to bench. Chang Gung Med J. 2010;33(4):351-60 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/20804664

15. Ando W, Yamamoto K, Koyama T, Hashimoto Y, Tsujimoto T, Ohzono K. Radiologic and Clinical Features of Misdiagnosed Idiopathic Osteonecrosis of the Femoral Head. Orthopedics. 2017;40(1):e117-e23 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/27755641

16. Di Benedetto P, Niccoli G, Beltrame A, Gisonni R, Cainero V, Causero A. Histopathological aspects and staging systems in non-traumatic femoral head osteonecrosis: an overview of the literature. Acta Biomed. 2016;87 Suppl 1:15-24 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/27104316

17. Meier R, Kraus TM, Schaeffeler C, Torka S, Schlitter AM, Specht K, et al. Bone marrow oedema on MR imaging indicates ARCO stage 3 disease in patients with AVN of the femoral head. Eur Radiol. 2014;24(9):2271-8 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/24863885

18. Lee GC, Khoury V, Steinberg D, Kim W, Dalinka M, Steinberg M. How do radiologists evaluate osteonecrosis? Skeletal Radiol. 2014;43(5):607-14 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/24492890

19. Steinberg ME, Hayken GD, Steinberg DR. A quantitative system for staging avascular necrosis. J Bone Joint Surg Br. 1995;77(1):34-41 (Level II/III evidence). https://www.ncbi.nlm.nih.gov/pubmed/7822393

20. Stoica Z, Dumitrescu D, Popescu M, Gheonea I, Gabor M, Bogdan N. Imaging of avascular necrosis of femoral head: familiar methods and newer trends. Current health sciences journal. 2009;35(1):23-8 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/24778812 https://www.ncbi.nlm.nih.gov/pmc/PMC3945237/

21. Lau RL, Perruccio AV, Evans HM, Mahomed SR, Mahomed NN, Gandhi R. Stem cell therapy for the treatment of early stage avascular necrosis of the femoral head: a systematic review. BMC Musculoskelet Disord. 2014;15:156 (Level I evidence). https://www.ncbi.nlm.nih.gov/pubmed/24886648

22. Amanatullah DF, Strauss EJ, Di Cesare PE. Current management options for osteonecrosis of the femoral head: part II, operative management. Am J Orthop (Belle Mead NJ). 2011;40(10):E216-25 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/22263205

23. Mont MA, Zywiel MG, Marker DR, McGrath MS, Delanois RE. The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review. J Bone Joint Surg Am. 2010;92(12):2165-70 (Level I evidence). https://www.ncbi.nlm.nih.gov/pubmed/20844158

24. Zhao FC, Hu HX, Zheng X, Cang DW, Liu X, Zhang JZ, et al. Clinical analysis of 23 cases of steroid-associated osteonecrosis of the femoral head with normal initial magnetic resonance imaging presentation. Medicine (Baltimore). 2017;96(49):e8834 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/29245246

25. Guideline for Diagnostic and Treatment of Osteonecrosis of the Femoral Head. Orthop Surg. 2015;7(3):200-7 (Clinical guidelines). https://www.ncbi.nlm.nih.gov/pubmed/26311093

26. Mitchell MD, Kundel HL, Steinberg ME, Kressel HY, Alavi A, Axel L. Avascular necrosis of the hip: comparison of MR, CT, and scintigraphy. AJR Am J Roentgenol. 1986;147(1):67-71 (Level II/III evidence). https://www.ncbi.nlm.nih.gov/pubmed/3487233

27. Karantanas AH, Drakonaki EE. The role of MR imaging in avascular necrosis of the femoral head. Semin Musculoskelet Radiol. 2011;15(3):281-300 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/21644201

28. Roth A, Beckmann J, Bohndorf K, Fischer A, Heiss C, Kenn W, et al. S3-Guideline non-traumatic adult femoral head necrosis. Arch Orthop Trauma Surg. 2016;136(2):165-74 (Clinical guidelines). https://www.ncbi.nlm.nih.gov/pubmed/26667621

29. Yeh LR, Chen CK, Huang YL, Pan HB, Yang CF. Diagnostic performance of MR imaging in the assessment of subchondral fractures in avascular necrosis of the femoral head. Skeletal Radiol. 2009;38(6):559-64 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/19234700

30. Stevens K, Tao C, Lee SU, Salem N, Vandevenne J, Cheng C, et al. Subchondral fractures in osteonecrosis of the femoral head: comparison of radiography, CT, and MR imaging. AJR Am J Roentgenol. 2003;180(2):363-8 (Level II/III evidence). https://www.ncbi.nlm.nih.gov/pubmed/12540435

31. Agrawal K, Tripathy SK, Sen RK, Santhosh S, Bhattacharya A. Nuclear medicine imaging in osteonecrosis of hip: Old and current concepts. World journal of orthopedics. 2017;8(10):747-53 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/29094004 https://www.ncbi.nlm.nih.gov/pmc/PMC5656489/

32. Agarwal KK, Mukherjee A, Sharma P, Bal C, Kumar R. Incremental value of 99mTc-MDP hybrid SPECT/CT over planar scintigraphy and SPECT in avascular necrosis of the femoral head. Nucl Med Commun. 2015;36(10):1055-62 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/26308940

33. Luk WH, Au-Yeung AW, Yang MK. Diagnostic value of SPECT versus SPECT/CT in femoral avascular necrosis: preliminary results. Nucl Med Commun. 2010;31(11):958-61 (Level II/III evidence). https://www.ncbi.nlm.nih.gov/pubmed/20717063

34. Fan W, Zhu L, Chen J, Guo C, Yan Z. Identifying Patients Who Will Most Benefit from Single Photon Emission Computerized Tomography and Computerized Tomography After Femoral Neck Fracture. Med Sci Monit. 2017;23:5669-74 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/29182595

35. Barille MF, Wu JS, McMahon CJ. Femoral head avascular necrosis: a frequently missed incidental finding on multidetector CT. Clin Radiol. 2014;69(3):280-5 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/24295736

36. Chinese Guideline for the Diagnosis and Treatment of Osteonecrosis of the Femoral Head in Adults. Orthop Surg. 2017;9(1):3-12 (Clinical guidelines). https://www.ncbi.nlm.nih.gov/pubmed/28371498

37. Sun W, Wang BL, Li ZR. Chinese specialist consensus on diagnosis and treatment of osteonecrosis of the femoral head. Orthop Surg. 2011;3(2):131-7 (Clinical guidelines). https://www.ncbi.nlm.nih.gov/pubmed/22009599

Pathway User Guide

Yellow Boxes Denotes extra information. Some contain single or multiple white sub-boxes, click a white box to reveal detailed information in a pop-up.

White Boxes: Denotes standard pathway steps. (If inside a yellow box, they open a specific pop-up).

Zoom & Pan Controls: Use + / − or the slider to zoom. Reset returns to default. Tick Panning to drag the diagram when zoomed.

Blue “View Full Screen” Button: Opens the whole diagram in a large, full-screen pop-up window. Use Close to exit.

The relative radiation level (RRL) of each imaging investigation is displayed in the pop up box.

SYMBOL RRL EFFECTIVE DOSE RANGE
No radiation None 0
Minimal radiation Minimal < 1 millisieverts
Low radiation Low 1-5 mSv
Medium radiation Medium 5-10 mSv
High radiation High >10 mSv

Disclaimer

Status Of Recommendations Each pathway is designed to assist clinicians in situations when faced with a large array of possible diagnostic tests and examinations. However, it is recognised that diagnostic practice may differ from a particular pathway depending on local availability of equipment and expertise, as well as the experience of individual clinicians. Therefore each pathway is neither a rigid set of rules, nor a substitute for clinical assessment, and individual patient circumstances should always be considered.

Report an Issue

Spotted an error or outdated info? Click to tell us.

SUSPECTED AVASCULARNECROSIS(AVN) OFTHE HIP Plain radiographs Consider MRI fortreatment planning Consider CT if suspectedsubchondral fracture Normal or non-specific changes Positive for AVN Low clinical suspicion MRI High clinical suspicion Appropriate management depending on imaging findings MRI contraindicated or unavailable Stop CT Bone Scintigraphy or

Avascular Necrosis (AVN) of the Hip

Avascular necrosis refers to the death of bone and marrow cells due to interruption to their blood supply. This can result in joint destruction, pain and loss of hip function.

Avascular necrosis of the femoral head, or osteonecrosis of the femoral head, is the ischaemic death of the cellular elements of bone and marrow resulting from an interruption to their blood supply.

This can cause collapse and deformation of the femur, secondary osteoarthritis, and often results in loss of hip function and reduced quality of life

AVN can be non-traumatic or occur following trauma (e.g. femoral neck fracture, hip dislocation)

Risk factors for non-traumatic AVN include:

  • Corticosteroid use (long term corticosteroid use accounts for 10-30% of cases)
  • Alcohol use
  • Tobacco smoking
  • Collagen vascular disease
  • Haemoglobinopathies (e.g. Sickle cell disease)
  • Gaucher disease
  • Caisson disease
  • Some skeletal dysplasias
  • Chemotherapy
  • Radiotherapy
  • Pregnancy

Non-traumatic AVN most commonly affects people aged between 30-50 years. It is bilateral in 70-80% of cases

Imaging plays an important role in establishing the diagnosis of AVN

Identifying the disease stage, extent and location of necrosis are crucial to determine the best treatment, establish prognosis, and monitor progression

There are a number of staging systems used including:

  • The Ficat and Arlet system
  • The Steinberg University of Pennsylvania system
  • The Association for Research on Osseous Circulation (ARCO) system
  • The Japanese Orthopaedic Association system

Each staging system has limitations and no single system has been universally accepted. The ARCO staging system has been increasingly used in Europe

Treatment can include:

  • Conservative measures – e.g. activity modification and physical therapy
  • Medications - e.g. vasodilators/prostaglandin analogues, bisphosphonates, anticoagulants
  • Extracorporeal shock-wave treatment
  • Electromagnetic stimulation
  • Hyperbaric oxygen treatment
  • Surgery - e.g. decompression, osteotomy, bone grafting, multi-potential stem cells, and arthroplasty

If left untreated, subchondral fractures can occur. The majority of hips will progress to collapse and most patients will ultimately require hip arthroplasty. Early diagnosis and treatment can delay the need for joint replacement

Asymptomatic osteonecrosis (often detected when imaging the contralateral hip) will usually progress to symptomatic disease and femoral head collapse. When risk of progression is high (medium to large area, laterally located lesions), joint-preserving treatment should be considered to delay or slow the disease

Plain Radiography

Initial study of choice for suspected AVN. However, plain radiographs have a limited sensitivity for detecting early AVN and, when normal or non-specific changes are seen, further investigations may be necessary. In some centres, MRI is used as the first line imaging modality when there is a high clinical suspicion for AVN.

  • The recommended initial imaging study in patients with suspected AVN
  • An anteroposterior view of the pelvis and frog-leg lateral view of the hip should be performed
  • Relatively inexpensive and widely available
  • Radiographic findings in AVN may be normal, abnormal or equivocal
  • Identification of characteristic features (e.g. crescent sign) and detection of articular collapse, or demonstration of alternative diagnosis on radiographs may obviate the need for further imaging
  • However, given the low sensitivity for detecting early stage disease (as low as 41%), when plain radiographs are negative or equivocal further imaging is often required
  • In some centres, plain radiographs are not performed and MRI is used as the first line imaging modality when there is a high clinical suspicion for AVN

Magnetic Resonance Imaging (MRI)

Most accurate imaging modality for detection and staging of suspected AVN. In some centres, MRI is used as the first line imaging modality when there is a high clinical suspicion for AVN.

  • Currently the most accurate imaging modality to detect early AVN
  • If there is a strong clinical suspicion, MRI of both hips should be performed even if plain radiographs are normal
  • A systematic review of 43 studies found that MRI has an overall sensitivity of 93% and specificity of 91% for detecting early AVN, higher than other imaging modalities available
  • MRI demonstrates signal changes associated with osteocyte death and marrow fat cell replacement in early disease. It allows assessment of lesion stage, size and location which can help direct treatment and estimate prognosis
  • MRI can also demonstrate alternate pathology which may be contributing to the patient’s symptoms.
  • Routine MR imaging has limited sensitivity for the detection of subchondral fractures. When there is concern for a subchondral fracture, CT is recommended

Bone Scintigraphy

More sensitive than plain radiographs for detecting AVN; however, it has a lower sensitivity than MRI for detecting early AVN. Useful in more advanced disease and is particularly helpful to identify subchondral fractures.

  • Can detect early stages of AVN when radiographs are negative or inconclusive.
  • However, due to its lower spatial resolution, lower sensitivity and specificity, and inability to quantify the lesion, planar bone scintigraphy has largely been replaced by MRI
  • Sensitivity of bone scintigraphy varies significantly when comparing different studies (range: 75-91%). This may be because it has a higher sensitivity for detecting AVN in femoral neck fractures due to the sudden and nearly complete cut-off of blood supply, but is less sensitive in detecting AVN in chronic processes such as steroid-induced AVN
  • Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) has a higher anatomical resolution, sensitivity and specificity than SPECT as well as planar bone scintigraphy. Results from one study showed:
    • A sensitivity of 98% and specificity of 87% for SPECT/CT
    • A sensitivity of 75% and specificity of 40% for planar bone scintigraphy
  • Bone scintigraphy, particularly SPECT/CT, remains a valid alternative in suspected radiographically occult early AVN when MRI is contraindicated

Computed Tomography (CT)

Superior to plain radiographs but inferior to MRI for the early detection of AVN.

  • Higher sensitivity and specificity than plain radiography in overall detection of AVN, however, for early disease the sensitivity of CT is low (55%)
  • Although studies have reported CT to be less sensitive than both bone scintigraphy and MRI in detecting early AVN, it has been highlighted that few studies have used modern multi-detector CT scanners. It is argued that the true sensitivity is much higher when current-generation CT scanners are used and therefore CT is likely to play an increasing role in the future
  • Current American College of Radiology (ACR) guidelines recommend CT to further evaluate a patient with suspected AVN when radiographs are normal and MRI is contraindicated. It is thought that CT is more specific than bone scintigraphy and allows better anatomic assessment, however, SPECT/CT is more sensitive than CT
  • CT scans are more helpful in advanced disease (ARCO stage II and above), and are particularly useful to assess for subchondral fractures when this is not clearly defined on MRI
  • CT can determine the extent, severity and location of subchondral lucencies, sclerosis and articular collapse, and can demonstrate early secondary degenerative joint disease. It is a useful investigation to aid with surgical planning

  • Acute Abdomen
  • Breast
  • Cancer Staging
  • Cardiovascular
  • Ear, Nose & Throat
  • Endocrine
  • Gastrointestinal
  • Kidney and Urinary Tract
  • Liver and Biliary
  • Musculoskeletal Non-Trauma
  • Neurological
  • Obstetric & Gynaecological
  • Paediatric
  • Pancreas
  • Respiratory
  • Trauma
    • Trauma - Musculoskeletal
    • Trauma - Head
    • Trauma - Visceral
    • Trauma - Paediatric
  • Musculoskeletal Non-Trauma

    • Musculoskeletal Non-Trauma
      • Bone Metastases (Suspected)
      • Bone pain
      • Foot ulcer (diabetic)
      • Hip Avascular Necrosis (Suspected)
      • Hip pain (non-traumatic)
      • Knee pain (non-traumatic)
      • Low Back Pain (Acute)
      • Multiple Myeloma (Suspected)
      • Neck pain (non-traumatic)
      • Orbital Foreign Body (Suspected)
      • Osteomyelitis (suspected acute)
      • Shoulder Pain (Chronic)
      • Soft tissue mass
      • Temporomandibular Joint Disorders (Suspected)

    Diagnostic Imaging Pathways

    The DIP pathways are a step-by-step guides to help clinicians choose the most appropriate imaging for each clinical scenario 

    “Trusted by clinicians worldwide since 2007, Diagnostic Imaging Pathways provides clear, evidence-based imaging guidelines. Our pathways support better decision-making and help improve healthcare outcomes—especially in emerging nations. 

    DIP functions and thrives wholeheartedly under the pillars of diversity, inclusivity and respect for all."

    • Pathways
    • Normal Anatomy
    • Medical Images
    • Radiation Module
    • Radiation Quiz
    • Information for Consumers
    • Governance
    • About Imaging
    • Production
    • Search
    • Login
    • Get in Touch
    © Diagnostic Imaging Pathways (DIP) 2025
    Code of Conduct    Terms and Conditions of Use
    General Site Navigation

    Information For Consumers

    • General Information About Diagnostic Imaging
      • Colorectal (Bowel) Cancer Screening
      • Colorectal (Bowel) Cancer Screening (Australia)
      • Consent to Procedure or Treatment
      • Radiation Risks of X-rays and Scans
    • Imaging Pathways
      • Ankle Injury (Suspected)
      • Bowel Cancer (Staging)
      • Deep Venous Thrombosis ( Leg, Suspected)
      • Deep Venous Thrombosis (Arm, Suspected)
      • Headache (Constant or Repeated)
      • Hip Fracture (Suspected)
      • Hypertension
      • Low Back Pain (Acute)
      • Lung Cancer (Staging)
      • Neck Pain (Non-Traumatic)
      • Renal Colic
      • Respiratory Illness (Acute)
      • Scaphoid Fracture (Suspected)
      • Shoulder (Pain or Instability)
      • Sinusitis (Acute)
      • Sinusitis (Chronic)
      • Stress Fracture (Suspected)
    • Imaging Procedures
      • Angiography (Angiogram)
      • Arthrogram
      • Bone Scan
      • Computed Tomography (CT)
      • Computed Tomography (CT) Angiography
      • Inferior Vena Cava (IVC) Filters
      • Intravenous Pyelogram (IVP)
      • Magnetic Resonance Angiography (MRA)
      • Magnetic Resonance Imaging (MRI)
      • Myelogram
      • Orthopantomogram (OPG)
      • Percutaneous Transthoracic Fine Needle Aspiration (FNA) or Biopsy
      • Positron Emission Tomography (PET)
      • Renal Artery Angioplasty and Stent
      • Renal Scan
      • Ultrasound
      • Ultrasound (Doppler)
      • Ultrasound (Endoscopic Rectal)
      • Venography (Venogram)
      • X-ray (Chest)
      • X-ray (Plain Radiograph)

    Governance

    • History
      • 1990s to 2012
      • 2012 to 2016
      • 2016 to 11 April 2022
      • From 12 April 2022
      • Introduction
      • List of acronyms used on this site
    • Organisation
      • 2003 - 2012
      • 2013 - 2016
      • 2017 - 11 April 2022
      • Post 12 April 2022
    • Personnel
      • Clinical Advisors
      • Contractors
      • Contributors
      • Editor
      • Editorial Panel - Post 2022
      • Editorial Panel - Pre 2022
      • Executive Sponsor
      • Information Technologist
      • Manager
      • Other Personnel
      • Project Officers
      • Quality Coordinator
      • Research Registrar
      • Responsibilites
      • Steering Committee
      • Steering Committee
    • Responsibilities, Achievements
      • Accreditation and Endorsement
      • Clinical Advisors
      • Editor
      • Editorial Panel
      • Executive Sponsor
      • Information Technologist
      • Manager
      • Other Personnel
      • Pathway Creation, Review and Revision
      • Quality Coordinator
      • Research Registrar
      • Steering Committee

    About Imaging

    • About Imaging
      • Bleeding Risk and Assessment
      • General Principles in Requesting and Providing Imaging Investigations
      • Imaging During Pregnancy and Lactation
      • Ionising Radiation in Diagnostic Imaging
      • Ionising Radiation in Paediatric Imaging
    • Common Procedures
      • Computed Tomography
      • Gastrointestinal Contrast Examinations
      • High Resolution Computed Tomography
      • Magnetic Resonance Imaging
      • Nuclear Medicine
      • Positron Emission Tomography
      • Ultrasound
    • Contrast Agents
      • Gadolinium Contrast for MRI scans
      • Iodinated Contrast for CT scans
      • Ultrasound Contrast Media

    Production

    • Editorial Independence
      • Disclosure of Conflict of Interest
      • Funding Policy & Sources
      • Management of Conflict of Interest
    • Processes for Creating and Managing Content
      • Creation of a New Pathway
      • Creation of New Information for Consumers
      • Review and Revision of a Pathway
      • Review and Revision of Information for Consumers
    • Production
      • Initial Engagement with Consumers
      • Principles for Creating and Managing Content